Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down's syndrome by Pérez Cremades, Daniel et al.
BASIC NEUROSCIENCES, GENETICS AND IMMUNOLOGY - ORIGINAL ARTICLE
Alteration of inhibitory circuits in the somatosensory cortex
of Ts65Dn mice, a model for Down’s syndrome
D. Pe´rez-Cremades • S. Herna´ndez • J. M. Blasco-Iba´n˜ez •
C. Crespo • J. Nacher • E. Varea
Received: 17 September 2009 / Accepted: 27 January 2010 / Published online: 16 February 2010
 Springer-Verlag 2010
Abstract Down’s syndrome (DS), with an incidence of
one in 800 live births, is the most common genetic disorder
associated with mental retardation. This trisomy on chro-
mosome 21 induces a variable phenotype in which the only
common feature is the presence of mental retardation. The
neural mechanisms underlying mental retardation might
include defects in the formation of neuronal networks and
neural plasticity. DS patients have alterations in the mor-
phology, the density and the distribution of dendritic spines
in the pyramidal neurons of the cortex. Our hypothesis is
that the deficits in dendritic arborization observed in the
principal neurons of DS patients and Ts65Dn mice (a
model for DS that mimics most of the structural alterations
observed in humans) may be mediated to some extent by
changes in their inhibitory inputs. Different types of
interneurons control different types of inhibition. There-
fore, to understand well the changes in inhibition in DS, it
is necessary to study the different types of interneurons
separately. We have studied the expression of synapto-
physin, Glutamic acid decarboxylase-67 (GAD-67) and
calcium-binding protein-expressing cells in the primary
somatosensory cortex of 4–5 month old Ts65Dn mice. We
have observed an increment of GAD67 immunoreactivity
that is related mainly to an increment of calretinin-immu-
noreactive cells and among them the ones with bipolar
morphology. Since there is a propensity for epilepsy in DS
patients, this increase in interneurons might reflect an
attempt by the system to block overexcitation rather than
an increment in total inhibition and could explain the
deficit in interneurons and principal cells observed in
elderly DS patients.
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Introduction
Down’s syndrome (DS), with an incidence of one in 800
live births (Roizen and Patterson 2003), is one of the most
common genetic disorders. Trisomy on the chromosome 21
induces a variable phenotype that may include immune
deficiencies, heart defects, increased risk of leukaemia and
early development of Alzheimer’s disease. However, the
only common feature among all DS individuals is the
presence of mental retardation. The neural mechanisms
underlying this retardation may include defects in the for-
mation of neuronal networks, information processing and
brain plasticity. Dendritic abnormalities in DS are an index
of major neuronal disruption. Changes in dendritic archi-
tecture correlate to some extent with the cognitive profile
(Dierssen and Ramakers 2006).
Several models are available to mimic the alterations in
DS. The most used is the Ts65Dn mouse. This model is
segmentally trisomic for a portion of the mouse chromo-
some 16 that is orthologous to the long arm of the human
chromosome 21. This segment contains approximately 140
genes, many of which are highly conserved between mice
and humans (Gardiner et al. 2003). These mice display
delays in the acquisition of a number of sensory and motor
tasks (Holtzman et al. 1996; Costa et al. 1999), as well as
defects in learning and in the execution of memory tasks
mediated by the hippocampus (Reeves et al. 1995; Escori-
huela et al. 1995, 1998; Holtzman et al. 1996).
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Several studies have pointed out the possibility of
alterations in the number and distribution of synapses in
DS patients and in murine models. A reduction in the
number of asymmetric (excitatory) synapses per neuron has
been shown in the different regions of the hippocampus, as
well as in the temporal cortex of Ts65Dn mice (Kurt et al.
2000). Moreover, the area occupied by synaptophysin (a
reliable marker for synapses (Eastwood and Harrison 2001;
Masliah et al. 1990) is higher in these mice when compared
with the euploids, suggesting an increase in the size of the
synapse (Belichenko et al. 2004). Finally, there is a clear
redistribution of the inhibitory contacts on the dendrites of
these mice: there is an increase in the density of contacts on
spines and a decrease of those on dendritic shafts (Beli-
chenko et al. 2004). Altogether, these results suggest an
unbalanced level of inhibitory and excitatory inputs in the
neocortex and the hippocampus in DS. Supporting this fact,
an overactivation of the inhibitory system causing a general
inhibition in the brain has been observed in Ts65Dn mice
(Fernandez et al. 2007). This increased inhibition may be
responsible, at least to some extent, for the cognitive
impairment observed in DS. In fact, some studies have
attempted to reverse the cognitive impairments observed in
Ts65Dn mice by using GABAA receptor antagonists (Fer-
nandez et al. 2007), obtaining promising results.
Many studies have shown deficits in the dendritic
arborisation of the principal cells of the neocortex of DS
patients (Marin-Padilla 1976; Becker et al. 1986; Vuksic
et al. 2002). Similar results have been observed in the
Ts65Dn mouse model (Takashima et al. 1981, 1989;
Kaufmann and Moser 2000; Dierssen et al. 2003). The
dendritic atrophy could be related to the increased inhibi-
tion observed in the patients and models of DS.
Our hypothesis is that the deficits in dendritic arboriza-
tion observed in the principal neurons of Neocortex of DS
individuals and Ts65Dn mice could be mediated by changes
in their inhibitory inputs. Cortical interneurons can be
divided into different subpopulations defined by their
immunochemical characteristics such as the expression of
the calcium-binding proteins calretinin, parvalbumin and
calbindin D-28k. Post-mortem studies in individuals with
DS reveal a reduction in the number of calbindin D-28k and
parvalbumin interneurons in elderly individuals (Kobayashi
et al. 1990) as well as a general reduction in the number of
interneurons in Layer II and IV (Ross et al. 1984).
The Ts65Dn mouse displays a reduction in the number
of calbindin D-28k-expressing neurons of the hippocampus
as well as in the intensity of the calbindin D-28k immu-
noreactivity in the neuropil in the hippocampus. By con-
trast, the number of calretinin- and parvalbumin-expressing
interneurons in the hippocampus are unaltered (Hunter
et al. 2004), but the effect in the neocortex is totally
unknown.
We analysed the distribution of the different subpopu-
lations of interneurons in the primary somatosensory cortex
of Ts65Dn mice in order to analyse possible alterations in
their inhibitory pathways. We chose this region because
previous studies have described alterations in their princi-
pal neurons (Dierssen et al. 2003). We have quantified the
expression of synaptic markers in the neuropil and the
number of total interneurons (GAD-67 expressing cells) as
well as the number of calbindin D-28k, parvalbumin-, and
calretinin-expressing interneurons in the somatosensory
cortex of Ts65Dn mice.
Materials and methods
Experimental mice were generated by repeated back-
crossing of Ts65Dn females to C57/6Ei 9 C3H/HeSnJ
(B6EiC3) F1 hybrid males. The parental generation was
obtained from the research colony of Jackson Laboratory.
Euploid littermates of Ts65Dn mice served as controls. For
this study we used four- to five-month-old male mice
(9 trisomic mice and 12 euploid mice).
Animals were transcardially perfused using a solution
containing paraformaldehyde 4% in PB (0.1 M, pH 7.4).
Brains were removed and cryoprotected using sucrose
30%. Fifty microns sections (10 subseries for each brain)
were obtained using a sliding freezing microtome.
Immunohistochemical procedure
Tissue was processed ‘‘free-floating’’ for immunohisto-
chemistry as follows. Briefly, sections were incubated with
10% methanol, 3% H2O2 in phosphate
-buffered saline
(PBS) for 10 min to block endogenous peroxidase activity.
After this, sections were treated for 1 h with 5% normal
donkey serum (NDS) (Jackson ImmunoResearch Labora-
tories, West Grove, PA, USA) in PBS with 0.2% Triton-
X100 (Sigma-Aldrich, St Louis, MO, USA) and were
incubated overnight at room temperature either in mono-
clonal mouse anti-synaptophysin (1:200; Sigma-Aldrich),
polyclonal rabbit anti-GAD-67 (1:1,000, Chemicon Int.
Inc., Temecula, CA, USA), monoclonal mouse anti-GAD-
67 (1:500, Chemicon Int. Inc., Temecula, CA, USA),
polyclonal rabbit anti-calbindin D-28k (1:2,000, SWANT,
Bellinzona, Switzerland), polyclonal rabbit anti-parvalbu-
min (1:2,000, SWANT, Bellinzona, Switzerland) or poly-
clonal rabbit anti-calretinin (1:2,000, SWANT, Bellinzona,
Switzerland) antibodies. After washing, sections were
incubated for 2 h with donkey anti-mouse IgG or donkey
anti-rabbit IgG biotinylated antibodies (1:250; Jackson
ImmunoResearch Laboratories, West Grove, PA, USA),
followed by avidin–biotin–peroxidase complex (ABC;
Vector Laboratories, Peterborough, UK) for 30 min in PBS
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containing 0.2% Triton-X-100, and 3% NDS was used for
primary and secondary antibodies’ dilutions. Colour
development was achieved by incubating with 0.05% 3,30-
diaminobenzidine tetrahydrochloride (Sigma-Aldrich) and
0.033% hydrogen peroxide in PB for 4 min.
The antibodies had been previously tested in their lab-
oratory of origin; also they showed a regional and cellular
immunolabelling similar to previous descriptions of these
antigens. In order to confirm that some of the immuno-
staining was not produced by the secondary antibodies or
by the immunocytochemical protocol, we omitted primary
antibodies or substituted them by normal donkey serum.
These controls resulted in a complete absence of immu-
nostaining in every case.
Density of synaptic markers in the neuropil
We have analysed the intensity of the staining for synap-
tophysin (total synapses) and GAD-67 (inhibitory syn-
apses) in three sections per animal corresponding to the
somatosensory cortex. In order to analyse the staining we
used a previously described methodology (Varea et al.
2007). Sections were examined with an Olympus CX41
microscope under bright-field illumination, homoge-
neously lighted and digitalized using a CCD camera.
Photographs were taken at 209 magnification. Grey levels
were measured using Image J software (NIH). Means were
determined for each experimental group (Ts65Dn vs.
euploid littermates) and data were statistically analysed
using the SPSS software package (version 15). The dif-
ferences between groups have been analysed with repeated
measure ANOVA and post-hoc tests.
Density of inhibitory neurons in Ts65Dn
We have analysed changes in the distribution of
GABAergic interneurons (using immunohistochemistry for
GAD-67) and of specific subpopulations (using immuno-
histochemistry against calbindin D-28k, calretinin and
parvalbumin) in the Ts65Dn mice, and in their euploid
littermates. We counted the number of immunoreactive
cells found in 500-lm-wide strips (20 strips per group)
running perpendicular to the pial surface including all the
layers of the primary somatosensory cortex. Also we con-
sidered number of cells in every layer (Berbel et al. 1996).
After measuring the extension of the different layers, we
calculated the cellular density in every layer and in the total
somatosensory cortex. Means were determined for each
experimental group and data were statistically analysed
using the SPSS software package (version 15). The dif-
ference between groups was analysed with repeated mea-
sure ANOVA and post-hoc tests. Nissl-stained sections
adjacent to the ones measured were used to determine the
location of cortical layers.
Results
Expression of synaptic markers in the neuropil
of the somatosensory cortex
Synaptophysin
The analysis of synaptophysin immunoreactivity showed a
punctate appearance in the neuropil, whereas cell somata
were devoid of staining. The immunostaining was more
intense in the superficial layers than the deep ones. There is
a thin strip of lighter labelling in Layer IV (Fig. 1b–e). In
trisomic mice, we observed higher levels of synaptophysin
expression when compared with their euploid littermates,
especially in the superficial layers of the somatosensory
cortex (Fig. 1a). These differences were statistically sig-
nificant for Layers I, II and III (P \ 0.05). These results
were in accordance with previous data obtained in other
cortical areas in this DS model (Belichenko et al. 2004).
Glutamic acid decarboxylase-67
The immunoreactivity revealed a diffuse pattern of stain-
ing, showing higher intensity in the superficial layers. Of
the two antibodies used for the study of GAD-67 expres-
sion, the polyclonal one labels cell somata poorly; there-
fore the presence of cell bodies is quite scarce. The fine
analysis of the immunolabelling revealed a punctate
staining, similar to that observed for synaptophysin
(Fig. 1g–j). TS65Dn mice displayed a higher expression
(statistically significant) of GAD-67 in the neuropil of all
layers with the exception of Layer I (Fig. 1f).
Interneuron distribution
We analysed the density and distribution of inhibitory
neurons in the primary somatosensory cortex of Ts65Dn
mice. Inhibitory neurons were widely distributed all over
the somatosensory cortex (Fig. 2). There was a higher
density in Layer III, but neurons were abundant in all
layers except in Layer I. As a general trend, we observed an
increment in the density of interneurons in the whole
somatosensory cortex of trisomic mice (6848 ± 544 cells/
mm3 vs. 5048 ± 349 cells/mm3, P \ 0.05) (Fig. 2a). The
study of the expression per layer revealed a statistically
significant increment in the number of interneurons in
Layers III, IV, V and VI (Fig. 2b).




synaptophysin and GAD67 IR
in the somatosensory cortex of
the Ts65Dn mice. Diagram
showing changes in the
expression of synaptophysin in
the different layers of the
somatosensory cortex in euploid
(black bar) and Ts65Dn mice
(white bar) (a). Example of the
expression of synaptophysin in
Layer II (b, c) and Layer V
(d, e) in euploid (b, d) and
Ts65Dn mice (c, e). Diagram
showing changes in the
expression of GAD-67 in the
different layers of the
somatosensory cortex in euploid
(black bar) and Ts65Dn mice
(white bar) (a). Example of the
expression of GAD-67 in Layer
II (b, c) and Layer V (d, e) in
euploid (b, d) and Ts65Dn mice
(c, e). Scale bar 25 lm
(*P \ 0.05; **P \ 0.01)
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Next, we analysed if the changes in the number of
GABAergic neurons were due to a change in a specific
subpopulation of interneurons, for which we analysed the
expression of calcium-binding proteins (calbindin D-28k,
parvalbumin and calretinin).
Calbindin D-28k-immunoreactive neurons were distrib-
uted all over the layers excepting layer I, but they were
most abundant in the deeper layers (V-VI) (Fig. 3). The
analysis of calbindin D-28k expression revealed a slight
increase in the number of neurons in the somatosensory
cortex of Ts65Dn (849 ± 74 cells/mm3 vs. 776 ± 81 cells/
mm3, n.s.) (Fig. 3a). A more detailed study revealed that
the increase was specific to layer VI, where it was statis-
tically significant (1881 ± 229 cells/mm3 vs. 1213 ± 213
cells/mm3, P \ 0.05) (Fig. 3b).
Neurons expressing parvalbumin were more abundant
than those expressing calbindin D-28k. The study of their
distribution revealed that they were abundant in layers III
to V whereas layer I was almost devoid of them (Fig. 4).
The analysis of the parvalbumin expression also revealed a
slight increase in the total density of neurons in the whole
somatosensory cortex of Ts65Dn mice (1691 ± 98 cells/
mm3 vs. 1361 ± 143 cells/mm3, P = 0,105; n. s.) (Fig. 4a).
This increase was more evident in layers IV and V. Layer IV
displayed the highest increment (1560 ± 87 cells/mm3 vs.
1079 ± 108 cells/mm3, P \ 0.01); layer V also displayed a
high increase in the density of parvalbumin immunoreactive
neurons (3582 ± 143 cells/mm3 vs. 2929 ± 234 cells/mm3,
P \ 0.05) (Fig. 4b).
Finally, the interneurons expressing calretinin were as
abundant as the ones expressing calbindin D-28k, but they
were mainly located in the superficial and middle layers
(I-IV) (Fig. 5). The analysis of the number of calretinin-
expressing interneurons revealed that this subpopulation
was the most affected in this model. Ts65Dn mice dis-
played a higher density of calretinin-immunoreactive
Fig. 2 Alterations in the
density and distribution of total
interneurons (GAD67 IR) in the
somatosensory cortex of the
Ts65Dn mice. a Graph showing
the total density of interneurons
in the primary somatosensory
cortex of euploid (black bar)
and Ts65Dn mice (white bar).
b Graph showing the density of
interneurons in every layer of
the primary somatosensory
cortex in euploid and Ts65Dn
mice. Field survey of the
somatosensory cortex of a
control (c) and a Ts65Dn mouse
(d), showing the distribution of
total interneurons. Scale bar
200 lm (*P \ 0.05;
**P \ 0.01)
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neurons in the somatosensory cortex as a whole (1515 ± 87
cells/mm3 vs. 1005 ± 91 cells/mm3, P \ 0.01) (Fig. 5a).
The detailed study of calretinin density in each layer of
the somatosensory cortex revealed that the increment was
only statistically significant in layers III and IV. Layer III
displayed almost double density of calretinin-immunor-
eactive neurons in Ts65Dn mice when compared with
controls (2910 ± 190 cells/mm3 vs. 1663 ± 199 cells/mm3,
P \ 0.001). Layer IV also displayed a higher density of
calretinin-immunoreactive neurons in Ts65Dn mice
(1443 ± 73 cells/mm3 vs. 987 ± 80 cells/mm3, P \ 0.01)
(Fig. 5b).
Two main morphological types of calretinin-immu-
noreactive neurons have been described in the neocortex
(bipolar-BCR and multipolar-MCR). We have analysed
separately the possible alteration of these populations
in the Ts65Dn mice. BCR (Fig. 6a) represent around
one-third of the calretinin-expressing interneurons.
Ts65Dn mice displayed a clear increment of BCR in the
primary somatosensory cortex (550 ± 39 cells/mm3 vs.
299 ± 32 cells/mm3, P \ 0.01) (Fig. 6c). The detailed
study of BCR density in each layer of the somatosensory
cortex revealed that the increment was statistically sig-
nificant for layer III (1079 ± 67 cells/mm3 vs. 512 ± 73
cells/mm3, P \ 0.001) (Fig. 6e). The MCR interneurons
(Fig. 6b) represented around two-thirds of the amount of
CR interneurons. Ts65Dn mice displayed an increase of
MCR in the primary somatosensory cortex (965 ± 68
cells/mm3 vs. 706 ± 73 cells/mm3, P \ 0.05) (Fig. 6d).
The detailed study of MCR density in each layer
of the somatosensory cortex revealed that the incre-
ment was statistically significant only for layer III
(1831 ± 169 cells/mm3 vs. 1151 ± 152 cells/mm3,
P \ 0.05) (Fig. 6f).
Fig. 3 Alterations in the
density and distribution of
calbindin D-28k-
immunoreactive interneurons
(CB IR) in the somatosensory
cortex of the Ts65Dn mice.
a Graph showing the total
density of calbindin D-28k-
immunoreactive interneurons in
the primary somatosensory
cortex of euploid (black bar)
and Ts65Dn mice (white bar).
b Graph showing the density of
calbindin D-28k-
immunoreactive interneurons in
every layer of the primary
somatosensory cortex in euploid
and Ts65Dn mice. Field survey
of the somatosensory cortex of a
control (c) and a Ts65Dn (d),
showing the distribution of
calbindin D-28k-
immunoreactive interneurons.
Scale bar 200 lm (*P \ 0.05)
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Discussion
This study reveals an alteration of the inhibitory pathways
in the primary somatosensory cortex in Ts65Dn mice; this
cortical region presented a higher density of total inhibitory
neurons than in their euploid littermates. All the different
subpopulations of interneurons investigated in the present
study, using immunohistochemistry for the different cal-
cium-binding proteins, were more abundant in Ts65Dn
mice than in controls. However, the increment was espe-
cially relevant for calretinin-expressing cells and among
them the ones that displayed a bipolar morphology. These
alterations in the number of cortical interneurons can
influence the normal function of inhibitory circuits and
may underlie the cognitive deficits observed in different
pathologies, including DS. In fact, changes in the relative
proportions of different interneuron subtypes can cause
significant alterations in the properties of a modelled neu-
ronal network (Foldy et al. 2004).
There are several possibilities to explain that increase. It
could be due to an increased survival of calretinin-
expressing interneurons, or to changes in their migration,
integration and development. The source of calretinin-
immunoreactive interneurons is different from that of other
interneurons (Xu et al. 2003). Previous studies have failed
to label calretinin-expressing neurons by fate-mapping
cortical cells that derived from the medial ganglionar
eminence in vivo (Wichterle et al. 2001; Anderson et al.
2002), suggesting that these cells derived from a different
place or were produced at a different time during devel-
opment. Calretinin-expressing bipolar interneurons could
even originate from the cortex itself. Recent evidence from
explants of human embryos suggests that a substantial
number of cortical interneurons arise from the cortical
Fig. 4 Alterations in the
density and distribution of
parvalbumin-immunoreactive
interneurons (PV IR) in the
somatosensory cortex of
Ts65Dn mice. a Graph showing
the total density of
parvalbumin-immunoreactive
interneurons in the primary
somatosensory cortex of euploid
(black bar) and Ts65Dn mice
(white bar). b. Graph showing
the density of parvalbumin-
immunoreactive interneurons in
every layer of the primary
somatosensory cortex in euploid
and Ts65Dn mice. Field survey
of the somatosensory cortex of a
control (c) and a Ts65Dn (d),
showing the distribution of
parvalbumin-immunoreactive
interneurons. Scale bar 200 lm
(*P \ 0.05; **P \ 0.01)
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ventricular zone (Letinic et al. 2002). The density of
interneurons expressing calretinin appears to be develop-
mentally regulated in rodents, reaching a peak during the
first postnatal days and declining thereafter (Schierle et al.
1997), although most of these cells expressing transitorily
calretinin should be principal cells. In this context, newly
born cells in mice express transiently calretinin.
Another model in which calretinin-immunoreactive
neurons are overexpressed is in animals under early ethanol
exposure (Granato 2006). This early exposure to ethanol
may prevent the reduction of calretinin elements. Some-
thing similar could happen in the Down’s syndrome model.
In the same line of evidence, alterations in the distribution
of calretinin neurons, reflecting heterotopias caused by
migrational defects, have been observed in organotypic
cortical cultures treated with ethanol (Mooney et al. 2004).
Calretinin-expressing cells are not homogeneous
(Meskenaite 1997; Rogers 1992; Rogers and Resibois
1992). They include the Cajal-Retzius cells of layer I,
bipolar interneurons (elongated soma with one of two
dendrites oriented vertically) and multipolar interneurons
(round cell bodies with multiple primary dendrites) (Conde
et al. 1994; Gabbott and Bacon 1996; Meskenaite 1997;
Caputi et al. 2009). It seems that Cajal-Retzius cells are
unaltered since the fact that calretinin-immunoreactive
neurons in layer I remain unaltered in Ts65Dn. The other
two populations of calretinin-immunoreactive interneu-
rons, i.e. the one with bipolar morphology (BCR) and the
other with multipolar morphology (MCR) are affected in
Ts65Dn. The densities of both types were increased in the
primary somatosensory cortex of Ts65Dn mice. This
increment is mainly located in layer III. However, the
subpopulation of BCR was more affected than the one of
MCR. Functionally, MCR cells seem to be involved in the
maintenance of rhythmic activity (theta frequency oscilla-
tions), and BCR cells act as ‘‘disinhibitory’’ cells relieving
Fig. 5 Alterations in the
density and distribution of
calretinin immunoreactive
interneurons (CR IR) in the
somatosensory cortex of
Ts65Dn mice. a Graph showing
the total density of calretinin-
immunoreactive interneurons in
the primary somatosensory
cortex of euploid (black bar)
and Ts65Dn mice (white bar).
b Graph showing the density of
calretinin-immunoreactive
interneurons in every layer of
the primary somatosensory
cortex in euploid and Ts65Dn
mice. Field survey of the
somatosensory cortex of a
control (c) or a Ts65Dn (d)
showing the distribution of
calretinin-immunoreactive
interneurons. Scale bar 200 lm
(*P \ 0.05; **P \ 0.01;
***P \ 0.001)
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layer 2/3 pyramidal cells from inhibition (Caputi et al.
2009). BCR cells in the neocortex are interneuron-selective
(IS) cells and seem to target specifically other interneurons
(Gonchar and Burkhalter 1999).
The increase in the density of total inhibitory neurons in
the somatosensory cortex could reveal a higher level of
inhibition. Previous studies have pointed a higher level of
inhibition in some regions of the neocortex and the hip-
pocampus (Belichenko et al. 2004, 2007, 2009; Kurt et al.
2000). In this sense, treatment with picrotoxin (a GABAA
receptor antagonist), improves behavioural performance
(Fernandez et al. 2007). Our study goes deeper analysing
the different subpopulations of interneurons. Different
types of interneurons display different roles in the cortex.
Parvalbumin-immunoreactive interneurons are fast
spiking cells that are divided into two main types of
interneurons: chandelier cells (that connect with principal
neurons in the initial segment of the axon) and basket cells
that make perisomatic inhibition. They control mainly
network synchronisation.
MCR and calbindin D-28k interneurons are regular
spiking cells involved in the control of the signalling on
principal cells and signal integration (Cauli et al. 1997;
Markram et al. 2004).
Fig. 6 Alterations in the




(CR IR) in the somatosensory
cortex of Ts65Dn mice. a Image
of a Bipolar cell (BCR).
b Image of a Multipolar cell
(MCR). c Graph showing the
total density of BCR
interneurons in the primary
somatosensory cortex of euploid
(black bar) and Ts65Dn mice
(white bar). d Graph showing
the total density of MCR
interneurons in the primary
somatosensory cortex of euploid
and Ts65Dn mice. e Graph
showing the density of BCR
interneurons in every layer of
the primary somatosensory
cortex in euploid and Ts65Dn
mice. f Graph showing the
density of MCR interneurons in
every layer of the primary
somatosensory cortex in euploid
and Ts65Dn mice. Scale bar
25 lm (*P \ 0.05; **P \ 0.01;
***P \ 0.001)
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BRC neurons inhibit other interneurons producing as a
final result the disinhibition of the system. They are feed-
forward activated by the same inputs that activate the
principal cells and seem able to control the function of the
other interneurons. However, not all types of interneurons
are equally innervated by them.
Therefore, the neuronal inhibition is a complex process
that cannot be reduced to simply the opposite of excitation.
For this reason the separated study of the different sub-
populations in every area is necessary to fully understand
the inhibitory balance.
Then, although it would be tempting to interpret this
increment of interneurons as an increase of inhibition in
patients with Down’s syndrome, the high susceptibility to
epilepsy that they present (Stafstrom 1993) indicates rather
the contrary. Epilepsy has been related to the alteration in
the balance between excitation and inhibition. The incre-
ment in interneurons could reflect an attempt by the system
to cope with the overexcitation.
This hypothesis could support the discrepancies of the
results obtained in the cortex of elderly patients suffering
Down’s syndrome. A reduction in the number of total
interneurons (Ross et al. 1984) and more specifically in the
number of calbindin D-28k and parvalbumin interneurons
(Kobayashi et al. 1990) has been observed. This overall
overexcitation in DS could be reflected as an increase in the
number of interneurons in young adult animals, but could
lead to excitotoxicity with the result of increased neuronal
death during ageing affecting both interneurons and prin-
cipal cells.
The study of the alterations in the different types of
inhibition in DS can shed light on the processes leading to
the neurological deficits and can help to design novel
strategies to contain the mental retardation associated with
this disorder.
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